Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters.
Saved in:
| Title: | Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters. |
|---|---|
| Authors: | Stark, Felicity C.1 (AUTHOR), Akache, Bassel1 (AUTHOR) Bassel.akache@nrc-cnrc.gc.ca, Deschatelets, Lise1 (AUTHOR), Tran, Anh1 (AUTHOR), Stuible, Matthew1 (AUTHOR), Durocher, Yves1 (AUTHOR), McCluskie, Michael J.1 (AUTHOR), Agbayani, Gerard1 (AUTHOR), Dudani, Renu1 (AUTHOR), Harrison, Blair A.1 (AUTHOR), Renner, Tyler M.1 (AUTHOR), Makinen, Shawn R.1 (AUTHOR), Bavananthasivam, Jegarubee1 (AUTHOR), Duque, Diana1 (AUTHOR), Gagne, Martin2 (AUTHOR), Zimmermann, Joseph3 (AUTHOR), Zarley, C. David4,5 (AUTHOR), Cochrane, Terrence R.4,6 (AUTHOR), Handfield, Martin4 (AUTHOR) |
| Source: | Scientific Reports. 6/13/2022, Vol. 12 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
